190 related articles for article (PubMed ID: 27723100)
21. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
Arnold J; Sangwaiya A; Bhatkal B; Arnold A
Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
[TBL] [Abstract][Full Text] [Related]
22. [Hereditary hemochromatosis].
Dantas W
Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
[TBL] [Abstract][Full Text] [Related]
23. How should hyperferritinaemia be investigated and managed?
Ong SY; Nicoll AJ; Delatycki MB
Eur J Intern Med; 2016 Sep; 33():21-7. PubMed ID: 27346296
[TBL] [Abstract][Full Text] [Related]
24. Iron mobilization using chelation and phlebotomy.
Flaten TP; Aaseth J; Andersen O; Kontoghiorghes GJ
J Trace Elem Med Biol; 2012 Jun; 26(2-3):127-30. PubMed ID: 22565013
[TBL] [Abstract][Full Text] [Related]
25. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis.
Evers D; Kerkhoffs JL; Van Egmond L; Wijermans PW
Transfus Apher Sci; 2013 Apr; 48(2):187. PubMed ID: 23809828
[No Abstract] [Full Text] [Related]
26. Diagnosis and management of hereditary haemochromatosis.
Murphree CR; Nguyen NN; Raghunathan V; Olson SR; DeLoughery T; Shatzel JJ
Vox Sang; 2020 May; 115(4):255-262. PubMed ID: 32080859
[TBL] [Abstract][Full Text] [Related]
27. Does venesection reduce HIV viral load in patients with hereditary haemochromatosis?
Greaves DE; Griffiths WJ; Lever AM
Antivir Ther; 2013; 18(1):135-8. PubMed ID: 22898533
[TBL] [Abstract][Full Text] [Related]
28. Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.
Cançado R; Melo MR; de Moraes Bastos R; Santos PC; Guerra-Shinohara EM; Chiattone C; Ballas SK
Eur J Haematol; 2015 Dec; 95(6):545-50. PubMed ID: 25684349
[TBL] [Abstract][Full Text] [Related]
29. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment of genetic haemochromatosis].
Milman NT
Ugeskr Laeger; 2013 Apr; 175(16):1109-12. PubMed ID: 23651749
[TBL] [Abstract][Full Text] [Related]
31. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
[TBL] [Abstract][Full Text] [Related]
32. The liver in haemochromatosis.
Ulvik RJ
J Trace Elem Med Biol; 2015; 31():219-24. PubMed ID: 25204225
[TBL] [Abstract][Full Text] [Related]
33. Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications.
Czaja AJ
Aliment Pharmacol Ther; 2019 Mar; 49(6):681-701. PubMed ID: 30761559
[TBL] [Abstract][Full Text] [Related]
34. Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis.
van Aerts RM; van Deursen CT; Koek GH
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):147-52. PubMed ID: 26240005
[TBL] [Abstract][Full Text] [Related]
35. Iron saturation of ferritin in the course of phlebotomy treatment in patients with haemochromatosis.
ten Kate J; Marell K; Huizinga R; Kreeftenberg H; van Deursen C
Clin Chem Lab Med; 1999 Aug; 37(8):827-30. PubMed ID: 10536932
[TBL] [Abstract][Full Text] [Related]
36. Hereditary haemochromatosis.
Janssen MC; Swinkels DW
Best Pract Res Clin Gastroenterol; 2009; 23(2):171-83. PubMed ID: 19414144
[TBL] [Abstract][Full Text] [Related]
37. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
[TBL] [Abstract][Full Text] [Related]
38. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic venesection at the Australian Red Cross Blood Service: impact of the High Ferritin Application on management of hereditary haemochromatosis.
Bentley P; Bell B; Olynyk J
Aust Fam Physician; 2015 Aug; 44(8):589-92. PubMed ID: 26510149
[TBL] [Abstract][Full Text] [Related]
40. Pattern of care of blood donors with early-uncomplicated hereditary haemochromatosis in a Swiss blood donation centre.
Stefashyna O; Stern M; Infanti L; Holbro A; Tichelli A; Buser A; O'Meara A
Vox Sang; 2014 Feb; 106(2):111-7. PubMed ID: 23992555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
